These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 31696251)

  • 1. Towards a pro-resolving concept in systemic lupus erythematosus.
    Boeltz S; Hagen M; Knopf J; Mahajan A; Schick M; Zhao Y; Erfurt-Berge C; Rech J; Muñoz LE; Herrmann M
    Semin Immunopathol; 2019 Nov; 41(6):681-697. PubMed ID: 31696251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE.
    Muñoz LE; Janko C; Schulze C; Schorn C; Sarter K; Schett G; Herrmann M
    Autoimmun Rev; 2010 Nov; 10(1):38-42. PubMed ID: 20817127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies Recognizing Secondary NEcrotic Cells Promote Neutrophilic Phagocytosis and Identify Patients With Systemic Lupus Erythematosus.
    Biermann MHC; Boeltz S; Pieterse E; Knopf J; Rech J; Bilyy R; van der Vlag J; Tincani A; Distler JHW; Krönke G; Schett GA; Herrmann M; Muñoz LE
    Front Immunol; 2018; 9():989. PubMed ID: 29867966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory etiopathogenesis of systemic lupus erythematosus: an update.
    Podolska MJ; Biermann MH; Maueröder C; Hahn J; Herrmann M
    J Inflamm Res; 2015; 8():161-71. PubMed ID: 26316795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-dsDNA in the pathogenesis of systemic lupus erythematosus.
    Bai Y; Tong Y; Liu Y; Hu H
    Clin Exp Immunol; 2018 Jan; 191(1):1-10. PubMed ID: 28836661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE.
    Mahajan A; Herrmann M; Muñoz LE
    Front Immunol; 2016; 7():35. PubMed ID: 26904025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE).
    Janko C; Schorn C; Grossmayer GE; Frey B; Herrmann M; Gaipl US; Munoz LE
    Autoimmun Rev; 2008 Oct; 8(1):9-12. PubMed ID: 18703173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCARF1-Induced Efferocytosis Plays an Immunomodulatory Role in Humans, and Autoantibodies Targeting SCARF1 Are Produced in Patients with Systemic Lupus Erythematosus.
    Jorge AM; Lao T; Kim R; Licciardi S; El Khoury J; Luster AD; Means TK; Ramirez-Ortiz ZG
    J Immunol; 2022 Feb; 208(4):955-967. PubMed ID: 35082161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microparticles in systemic Lupus Erythematosus.
    Nielsen CT
    Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects.
    Soni C; Reizis B
    Front Immunol; 2019; 10():1601. PubMed ID: 31354738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus.
    Chavula T; To S; Smith J; Pedroza M; Nimri J; Devaraj S; Wenderfer S; Vogel TP; Agarwal SK
    J Autoimmun; 2024 May; 145():103197. PubMed ID: 38447248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in the pathogenesis of systemic lupus erythematosus.
    Munoz LE; van Bavel C; Franz S; Berden J; Herrmann M; van der Vlag J
    Lupus; 2008 May; 17(5):371-5. PubMed ID: 18490410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets.
    Biermann MH; Veissi S; Maueröder C; Chaurio R; Berens C; Herrmann M; Munoz LE
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1151-64. PubMed ID: 25081199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance deficiency and systemic lupus erythematosus (SLE).
    Gaipl US; Munoz LE; Grossmayer G; Lauber K; Franz S; Sarter K; Voll RE; Winkler T; Kuhn A; Kalden J; Kern P; Herrmann M
    J Autoimmun; 2007; 28(2-3):114-21. PubMed ID: 17368845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of dying cells and systemic lupus erythematosus.
    Grossmayer GE; Munoz LE; Gaipl US; Franz S; Sheriff A; Voll RE; Kalden JR; Herrmann M
    Mod Rheumatol; 2005; 15(6):383-90. PubMed ID: 17029100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage.
    Huang W; Wu J; Yang H; Xiong Y; Jiang R; Cui T; Ye D
    Cell Death Differ; 2017 Feb; 24(2):263-275. PubMed ID: 27768123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human neutrophils in auto-immunity.
    Thieblemont N; Wright HL; Edwards SW; Witko-Sarsat V
    Semin Immunol; 2016 Apr; 28(2):159-73. PubMed ID: 27036091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus.
    Yang F; He Y; Zhai Z; Sun E
    J Immunol Res; 2019; 2019():3638562. PubMed ID: 31871956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.